MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases

Medicine & Life Sciences

• Lipid Metabolism 78%
• MicroRNAs 68%
• Oxidative Stress 59%
• LDL Lipoproteins 55%
• Lipids 53%
• Lipoproteins 51%
• Reactive Oxygen Species 43%
• Gallstones 30%
• Non-alcoholic Fatty Liver Disease 29%
• HDL Lipoproteins 28%
• oxidized low density lipoprotein 27%
• Biological Phenomena 26%
• Oxidation-Reduction 26%
• Metabolic Syndrome 24%
• LDL Cholesterol 24%
• HDL Cholesterol 24%
• Iron 22%
• Atherosclerosis 21%
• Cholesterol 19%
• Homeostasis 19%
• Cardiovascular Diseases 19%
• Pathology 17%
• Glucose 17%
• Therapeutics 4%

Chemical Compounds

• MicroRNA 100%
• Low-Density Lipoprotein 95%
• Oxidative Stress 80%
• Pharmacological Metabolism 62%
• Lipoprotein 59%
• Lipid 56%
• Low-Density Lipoprotein Cholesterol 43%
• High-Density Lipoprotein Cholesterol 42%
• High-Density Lipoprotein 34%
• Plasma 33%
• Reactive Oxygen Metabolite 25%
• Cholesterol 24%
• Disorder 23%
• Metabolic 22%
• Glucose 19%
• Molecule 9%